These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34558308)

  • 21. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
    Chuong MD; Hartsell W; Larson G; Tsai H; Laramore GE; Rossi CJ; Wilkinson JB; Kaiser A; Vargas C
    Acta Oncol; 2018 Mar; 57(3):368-374. PubMed ID: 29034790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(1):1-142. PubMed ID: 34055109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
    Kubeš J; Vondráček V; Andrlik M; Navrátil M; Sláviková S; Vítek P; Rosina J; Abrahámová J; Prausová J; Grebenyuk A; Dědečková K
    J Med Imaging Radiat Oncol; 2019 Dec; 63(6):829-835. PubMed ID: 31486267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate bed irradiation with alternative radio-oncological approaches (PAROS) - a prospective, multicenter and randomized phase III trial.
    Koerber SA; Katayama S; Sander A; Jaekel C; Haefner MF; Debus J; Herfarth K
    Radiat Oncol; 2019 Jul; 14(1):122. PubMed ID: 31291969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton therapy for locally advanced non-small cell lung cancer.
    Gjyshi O; Liao Z
    Br J Radiol; 2020 Mar; 93(1107):20190378. PubMed ID: 31430188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer.
    Halpern JA; Sedrakyan A; Hsu WC; Mao J; Daskivich TJ; Nguyen PL; Golden EB; Kang J; Hu JC
    Cancer; 2016 Aug; 122(16):2496-504. PubMed ID: 27224858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton radiation for localized prostate cancer.
    Coen JJ; Zietman AL
    Nat Rev Urol; 2009 Jun; 6(6):324-30. PubMed ID: 19434101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anatomically robust proton therapy using multiple planning computed tomography scans for locally advanced prostate cancer.
    Busch K; Dahl B; Petersen SE; Rønde HS; Bentzen L; Pilskog S; Muren LP
    Acta Oncol; 2021 May; 60(5):598-604. PubMed ID: 33646069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies in clinical trials in proton radiotherapy: the present and the future.
    Miller RC; Lodge M; Murad MH; Jones B
    Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer.
    Nichols RC; Morris CG; Bryant C; Hoppe BS; Henderson RH; Mendenhall WM; Li Z; Costa JA; Williams CR; Mendenhall NP
    Cancer Invest; 2019; 37(2):85-89. PubMed ID: 30836776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the best way to radiate the prostate in 2016?
    Moon DH; Efstathiou JA; Chen RC
    Urol Oncol; 2017 Feb; 35(2):59-68. PubMed ID: 27395453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future technological developments in proton therapy - A predicted technological breakthrough.
    Vidal M; Moignier C; Patriarca A; Sotiropoulos M; Schneider T; De Marzi L
    Cancer Radiother; 2021 Oct; 25(6-7):554-564. PubMed ID: 34272182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):444-453. PubMed ID: 26907917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer.
    Pearlstein KA; Chen RC
    Semin Radiat Oncol; 2013 Jul; 23(3):182-90. PubMed ID: 23763884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Four-Year Outcomes From a Prospective Phase II Clinical Trial of Moderately Hypofractionated Proton Therapy for Localized Prostate Cancer.
    Grewal AS; Schonewolf C; Min EJ; Chao HH; Both S; Lam S; Mazzoni S; Bekelman J; Christodouleas J; Vapiwala N
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):713-722. PubMed ID: 31199994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.
    Dionisi F; Avery S; Lukens JN; Ding X; Kralik J; Kirk M; Roses RE; Amichetti M; Metz JM; Plastaras JP
    Acta Oncol; 2014 Oct; 53(10):1312-20. PubMed ID: 24797885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.